The Journal of Experimental Medicine
Symposium on Dendritic Cells
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published 20 October 2003. doi:10.1084/jem.20030351
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Humphreys, I. R.
Right arrow Articles by Hussell, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Humphreys, I. R.
Right arrow Articles by Hussell, T.
Right arrowPubmed/NCBI databases
*OMIM
Medline Plus Health Information
*Pneumonia
*Viral Infections
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
© Rockefeller University Press, 0022-1007/2003/10/1237 $5.00
The Journal of Experimental Medicine, Volume 198, Number 8, 1237-1242

A Critical Role for OX40 in T Cell–mediated Immunopathology during Lung Viral Infection

Ian R. Humphreys1, Gerhard Walzl1, Lorna Edwards1, Aaron Rae1, Sue Hill2 and Tracy Hussell1

1 Centre for Molecular Microbiology and Infection (CMMI), Biological Sciences, Imperial College of Science, Technology and Medicine, London SW7 2AZ, United Kingdom
2 Xenova Research Ltd., Cambridge CB4 0WG, United Kingdom

Address correspondence to Tracy Hussell, CMMI, Biological Sciences, Imperial College of Science, Technology and Medicine, Exhibition Road, London SW7 2AZ, United Kingdom. Phone: 44-207-5943091; Fax: 44-207-5943095; email: t.hussell{at}ic.ac.uk

Respiratory infections are the third leading cause of death worldwide. Illness is caused by pathogen replication and disruption of airway homeostasis by excessive expansion of cell numbers. One strategy to prevent lung immune–mediated damage involves reducing the cellular burden. To date, antiinflammatory strategies have affected both antigen-specific and naive immune repertoires. Here we report a novel form of immune intervention that specifically targets recently activated T cells alone. OX40 (CD134) is absent on naive T cells but up-regulated 1–2 d after antigen activation. OX40–immunoglobulin fusion proteins block the interaction of OX40 with its ligand on antigen-presenting cells and eliminate weight loss and cachexia without preventing virus clearance. Reduced proliferation and enhanced apoptosis of lung cells accompanied the improved clinical phenotype. Manipulation of this late costimulatory pathway has clear therapeutic potential for the treatment of dysregulated lung immune responses.

Key Words: costimulation • influenza • weight loss • inflammation


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS